Are invertebrates relevant models in ageing research? Focus on the effects of rapamycin on TOR

Mech Ageing Dev. 2016 Jan:153:22-9. doi: 10.1016/j.mad.2015.12.004. Epub 2016 Jan 4.

Abstract

Ageing is the organisms increased susceptibility to death, which is linked to accumulated damage in the cells and tissues. Ageing is a complex process regulated by crosstalk of various pathways in the cells. Ageing is highly regulated by the Target of Rapamycin (TOR) pathway activity. TOR is an evolutionary conserved key protein kinase in the TOR pathway that regulates growth, proliferation and cell metabolism in response to nutrients, growth factors and stress. Comparing the ageing process in invertebrate model organisms with relatively short lifespan with mammals provides valuable information about the molecular mechanisms underlying the ageing process faster than mammal systems. Inhibition of the TOR pathway activity via either genetic manipulation or rapamycin increases lifespan profoundly in most invertebrate model organisms. This contribution will review the recent findings in invertebrates concerning the TOR pathway and effects of TOR inhibition by rapamycin on lifespan. Besides some contradictory results, the majority points out that rapamycin induces longevity. This suggests that administration of rapamycin in invertebrates is a promising tool for pursuing the scientific puzzle of lifespan prolongation.

Keywords: Invertebrate; Longevity; Rapamycin; TOR.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aging*
  • Animals
  • Caenorhabditis elegans
  • Cell Proliferation
  • Disease Models, Animal*
  • Drosophila melanogaster
  • Female
  • Humans
  • Immunosuppressive Agents / chemistry*
  • Longevity
  • Male
  • Mice
  • Podospora
  • Saccharomyces cerevisiae
  • Schizosaccharomyces
  • Signal Transduction
  • Sirolimus / chemistry*
  • TOR Serine-Threonine Kinases / antagonists & inhibitors*
  • TOR Serine-Threonine Kinases / metabolism

Substances

  • Immunosuppressive Agents
  • TOR Serine-Threonine Kinases
  • Sirolimus